Literature DB >> 10908820

Eye irritation responses in rabbit and man after single applications of equal volumes of undiluted model liquid detergent products.

R Roggeband1, M York, M Pericoi, W Braun.   

Abstract

A criticism of the use of the rabbit low-volume eye test to determine eye irritation hazard for man is the lack of comparative data in man and rabbit with undiluted products. To address this, such a study has been performed in man and rabbit using undiluted model liquid detergents. The hypothesis tested was that if, under identical test conditions, the effects in the rabbit were the same or greater than the response in man, then it is valid to use the low-volume eye test to assess eye irritation hazard for man. The studies were carried out using 29 human volunteers and 12 rabbits. The effects in the rabbit were unequivocally greater than the effects observed in man, but clearly less than the expected response from these types of product in the Draize test. The results from this study confirm the sensitivity of the rabbit as a test species, and support the use of the low-volume eye test to assess eye irritation hazard for man. Any in vitro/ex vivo alternative to assess eye irritation should be developed against the rabbit low-volume eye test or human data where available.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908820     DOI: 10.1016/s0278-6915(00)00057-0

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  11 in total

Review 1.  In vitro reconstructed 3D corneal tissue models for ocular toxicology and ophthalmic drug development.

Authors:  Yulia Kaluzhny; Mitchell Klausner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-02-05       Impact factor: 2.416

2.  Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model.

Authors:  Su Khoh-Reiter; Bart A Jessen
Journal:  BMC Ophthalmol       Date:  2009-07-28       Impact factor: 2.209

3.  Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride.

Authors:  Hussein O Ammar; H A Salama; M Ghorab; A A Mahmoud
Journal:  AAPS PharmSciTech       Date:  2009-06-18       Impact factor: 3.246

Review 4.  The Nuremberg Code subverts human health and safety by requiring animal modeling.

Authors:  Ray Greek; Annalea Pippus; Lawrence A Hansen
Journal:  BMC Med Ethics       Date:  2012-07-08       Impact factor: 2.652

5.  Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension.

Authors:  Sophia K Mirza; Sandra M Johnson
Journal:  Clin Ophthalmol       Date:  2010-08-09

Review 6.  In Vitro Cell Models for Ophthalmic Drug Development Applications.

Authors:  Sara Shafaie; Victoria Hutter; Michael T Cook; Marc B Brown; David Y S Chau
Journal:  Biores Open Access       Date:  2016-04-01

7.  The Antifungal and Ocular Permeation of Ketoconazole from Ophthalmic Formulations Containing Trans-Ethosomes Nanoparticles.

Authors:  Tarek A Ahmed; Maram M Alzahrani; Alaa Sirwi; Nabil A Alhakamy
Journal:  Pharmaceutics       Date:  2021-01-24       Impact factor: 6.321

8.  Effective Ocular Delivery of Eplerenone Using Nanoengineered Lipid Carriers in Rabbit Model.

Authors:  Eman Abdelhakeem; Mohamed El-Nabarawi; Rehab Shamma
Journal:  Int J Nanomedicine       Date:  2021-07-22

9.  Retrospective analysis of the Draize test for serious eye damage/eye irritation: importance of understanding the in vivo endpoints under UN GHS/EU CLP for the development and evaluation of in vitro test methods.

Authors:  Els Adriaens; João Barroso; Chantra Eskes; Sebastian Hoffmann; Pauline McNamee; Nathalie Alépée; Sandrine Bessou-Touya; Ann De Smedt; Bart De Wever; Uwe Pfannenbecker; Magalie Tailhardat; Valérie Zuang
Journal:  Arch Toxicol       Date:  2013-12-28       Impact factor: 5.153

10.  Cyclosporine Amicellar delivery system for dry eyes.

Authors:  Han Kang; Kwang-Ho Cha; Wonkyung Cho; Junsung Park; Hee Jun Park; Bo Kyung Sun; Sang-Min Hyun; Sung-Joo Hwang
Journal:  Int J Nanomedicine       Date:  2016-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.